Analysis of the Role of Female Hormones During Infection by COVID-19
Abstract Women have metabolic, immunological, and genetic variables that ensure more protection from coronavirus infection. However, the indication of treatment for several pathologies and contraception is determined by hormones that have adverse effects and raise doubts about their use during the COVID-19 pandemic. Therefore, the present study searches women specificities and the relation between female sexual hormones and COVID-19, and reports the main recommendations in this background. To this end, a review of the literature was conducted in the main databases, auxiliary data sources, and official websites. Therefore, considering the hypercoagulability status of COVID-19, the debate about the use of contraceptives due to the relative risk of thromboembolic effects that they impose arises. However, the current available evidence, as well as the recommendations of main health organs around the world, demonstrate that the use of hormonal contraceptives must be maintained during the pandemic..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:43 |
|---|---|
| Enthalten in: |
Revista Brasileira de Ginecologia e Obstetrícia - 43(2022), 12, Seite 940-948 |
| Sprache: |
Englisch ; Portugiesisch |
|---|
| Beteiligte Personen: |
David Balbino Pascoal [VerfasserIn] |
|---|
| Links: |
doi.org [kostenfrei] |
|---|
| Themen: |
Contraception |
|---|
| doi: |
10.1055/s-0041-1740208 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
DOAJ073517437 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | DOAJ073517437 | ||
| 003 | DE-627 | ||
| 005 | 20230309115429.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230228s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1055/s-0041-1740208 |2 doi | |
| 035 | |a (DE-627)DOAJ073517437 | ||
| 035 | |a (DE-599)DOAJ1e61751e5e994525999cd3ac5cff3a2c | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng |a por | ||
| 050 | 0 | |a RG1-991 | |
| 100 | 0 | |a David Balbino Pascoal |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Analysis of the Role of Female Hormones During Infection by COVID-19 |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a Abstract Women have metabolic, immunological, and genetic variables that ensure more protection from coronavirus infection. However, the indication of treatment for several pathologies and contraception is determined by hormones that have adverse effects and raise doubts about their use during the COVID-19 pandemic. Therefore, the present study searches women specificities and the relation between female sexual hormones and COVID-19, and reports the main recommendations in this background. To this end, a review of the literature was conducted in the main databases, auxiliary data sources, and official websites. Therefore, considering the hypercoagulability status of COVID-19, the debate about the use of contraceptives due to the relative risk of thromboembolic effects that they impose arises. However, the current available evidence, as well as the recommendations of main health organs around the world, demonstrate that the use of hormonal contraceptives must be maintained during the pandemic. | ||
| 650 | 4 | |a woman | |
| 650 | 4 | |a hormones | |
| 650 | 4 | |a coronavirus | |
| 650 | 4 | |a thrombosis | |
| 650 | 4 | |a contraception | |
| 653 | 0 | |a Gynecology and obstetrics | |
| 700 | 0 | |a Isabela Macêdo de Araujo |e verfasserin |4 aut | |
| 700 | 0 | |a Lorenna Peixoto Lopes |e verfasserin |4 aut | |
| 700 | 0 | |a Cristiane Monteiro da Cruz |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i In |t Revista Brasileira de Ginecologia e Obstetrícia |d Federação Brasileira das Sociedades de Ginecologia e Obstetrícia, 2004 |g 43(2022), 12, Seite 940-948 |w (DE-627)DOAJ000091820 |x 01007203 |7 nnns |
| 773 | 1 | 8 | |g volume:43 |g year:2022 |g number:12 |g pages:940-948 |
| 856 | 4 | 0 | |u https://doi.org/10.1055/s-0041-1740208 |z kostenfrei |
| 856 | 4 | 0 | |u https://doaj.org/article/1e61751e5e994525999cd3ac5cff3a2c |z kostenfrei |
| 856 | 4 | 0 | |u http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-72032021001200940&lng=en&tlng=en |z kostenfrei |
| 856 | 4 | 0 | |u http://www.scielo.br/pdf/rbgo/v43n12/1806-9339-rbgo-43-12-0940.pdf |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/0100-7203 |y Journal toc |z kostenfrei |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_DOAJ | ||
| 951 | |a AR | ||
| 952 | |d 43 |j 2022 |e 12 |h 940-948 | ||